Efficacy of Tocilizumab in Patients with a Moderate and Severe COVID-19: A Retrospective Single Center Cohort Study

Efficacy of Tocilizumab in Patients with a Moderate and Severe COVID-19: A Retrospective Single Center Cohort Study

Introduction: Interleukin-6 (IL-6) is the key cytokine in “cytokine release syndrome” and associated with the lung fibrosis. Tocilizumab (TCZ) reduces the negative effects of inflammation by blocking the binding of IL-6 to its receptor. Materials and Methods: This was a retrospective observational...

Full description

Saved in:
Bibliographic Details
Main Authors: Sibel BOLUKÇU, Dilara KARAKUŞ, Gülay OKAY, Yasemin AKKOYUNLU, Bilge SÜMBÜL, Bülent DURDU, Meliha Meriç KOÇ, Turan ASLAN
Format: Article
Language:English
Published: Galenos Publishing House 2021-01-01
Series:Mediterranean Journal of Infection, Microbes and Antimicrobials
Subjects:
tocilizumab
il-6
covid-19
turkey
Online Access:http://mjima.org/abstract.php?id=297
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items